Navigation Links
Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/11/2010

contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. Serious anaphylactoid reactions, including death in a patient with asthma, have been reported in patients administered acetylcysteine intravenously. Acetadote should be used with caution in patients with asthma, or where there is a history of bronchospasm. The total volume administered should be adjusted for patients weighing less than 40 kg and for those requiring fluid restriction. To avoid fluid overload, the volume of diluent should be reduced as needed. If volume is not adjusted fluid overload can occur, potentially resulting in hyponatremia, seizure, and death.  For full prescribing information, visit www.acetadote.net.

ABOUT KRISTALOSEKristalose is indicated for the treatment of acute and chronic constipation.  It is a unique, proprietary, crystalline form of lactulose, with no restrictions on length of therapy or patient age. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia and hypernatremia. Nausea and vomiting have been reported. Use with caution in diabetics. Kristalose is contraindicated in patients who require a low-galactose diet. Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically. For full prescribing information, visit www.kristalose.com.

FORWARD-LOOKING STATEMENTSThis press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phas
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
3. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
4. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
5. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
6. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
7. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
8. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
9. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
10. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... Cell Research Products: Opportunities, Tools & Technologies" report ... supply stem cell research products or you wish to ... and lucrative this market is. The authors know you ... more effectively to scientists, to generate improved revenues and ...
(Date:8/22/2014)... Research and Markets has announced ... Catheter Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... industry with a focus on the Chinese situation. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:8/22/2014)... Cali ., Aug. 22, 2014  Research presented ... that a therapy being developed by Hera Therapeutics Inc. combats ... 70 percent of all cervical cancer. When tested ... of HPV-16, HPV-18 and HPV-11 cells, according to Louise ... who presented the findings at the Seattle ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Global and Chinese Intravenous Catheter Industry Report 2014 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... Qmed.com , the world,s only 100% qualified ... resource, today announced a new powerful business intelligence tool ... as part of its continuing commitment to provide users with ... "I am very pleased to announce that this new regulatory ...
... Mobility (USM) is excited to announce today that it has ... and merge its complex mobility business with USM. USM/TRS will ... Dana Mazer, ATP and his rehab team strengthens our position ... initiative in North Carolina. We are delighted to welcome their ...
Cached Medicine Technology:Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process 2Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process 3
(Date:8/22/2014)... A new study of self-awareness by Kessler ... (MS) may be able to improve their self-awareness ... ahead of print on July 2 in ... Nancy D. Chiaravalloti & John DeLuca: Metacognitive knowledge ... doi: 10.3233/NRE-141113). Self-awareness is one,s ability to recognize ...
(Date:8/22/2014)... Renal artery stenting to open blockages in ... historically been excluded from modern clinical trials, according ... in Catheterization and Cardiovascular Interventions today ... (SCAI). , University Hospitals Case Medical Center,s Sahil ... Professor of Medicine, Case Western Reserve University School ...
(Date:8/22/2014)... Home Care Assistance of Centennial ... seniors, is proud to announce the next installment in ... will feature Dr. Suzanne Steinbaum, attending cardiologist and Director ... New York City, National Spokesperson for the American Heart ... cover the issues surrounding women and heart disease, what ...
(Date:8/22/2014)... News) -- Many children get anxious or afraid when ... a number of ways that parents can make these ... The first step is to explain to children in ... health, said Rita John, director of the pediatric primary ... Nursing in New York City. "Children need to ...
(Date:8/22/2014)... In the previous few years, several breakthrough treatments ... cancer. Patients who may benefit from these treatments ... abnormalities in their cancer. For example, patients whose ... gene ALK derive significant benefit from the drug ... trials are now attempting to replicate this success ...
Breaking Medicine News(10 mins):Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4
... ... patients with visual impairments. , ... (PRWEB) February 3, 2010 -- Having nearly perfect vision may be attainable at any ... 20/20 vision, new corrective lens implants offer the possibility of enhanced clarity for patients young ...
... ... ... the human capital research firm, will host a webinar titled “Building Employee Engagement in ... February 24, 2010 at 1:00 p.m. EST. , , ,Join David Rowlee, Ph.D., ...
... , Feb. 2 Speedus Corp. (Nasdaq: SPDE ), ... from Nasdaq, in the form of a staff determination letter, informing the ... to the Company on December 11, 2009 to comply with ... requires the Company to maintain either (1) a minimum of $2.5 ...
... after they get the news, study finds , TUESDAY, Feb. ... be unnerving enough to up a man,s odds for either ... the study results didn,t surprise us," said study co-author Dr. ... Medical School. "A cancer diagnosis is an acutely distressful event, ...
... , NASHVILLE, Tenn. , Feb. 2 ... its common stock cash dividend for the quarter ended December ... per share, is payable on March 4, 2010 ... , Healthcare Realty Trust is a real estate investment trust that ...
... shocked to discover that virtually all human embryonic stem cell ... to line Petri dishes had left traces on the human ... body they likely would have been rejected by the patient,s ... approved for use in medical research, there remains a risk ...
Cached Medicine News:Health News:HD For More Than Your TV – New Technologies Offer Patients High Definition Vision At Any Age 2Health News:Morehead Presents Webinar on “Building Employee Engagement in a University Healthcare Environment” 2Health News:Speedus Receives and Appeals Nasdaq Notice 2Health News:Prostate Cancer Diagnosis Raises Suicide Risk 2Health News:Prostate Cancer Diagnosis Raises Suicide Risk 3Health News:Healthcare Realty Trust Announces Fourth Quarter Dividend 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 2Health News:3-D scaffold provides clean, biodegradable structure for stem cell growth 3
DRUGology is a source designed for primary care health providers, residents and medical students so that they may have a quick reference to treat a wide variety of conditions....
AHFS Patient Drug Information gives you a single source for providing important information and instructions for patients on dosing, precautions, possible side effects and interactions, and more....
... combination of new measuring principle - Pupil ... - SLD - offers high accuracy and ... ARK-530A/510A provides ordinary measurement (3.3 mm) using ... (6 mm) using 4 points, both of ...
... Sorting System RSD 800 is an individually ... (additional tube type identification via cap recognition ... various sample tubes in a clearly organized ... are customized and offer high capacity. The ...
Medicine Products: